Literature DB >> 24288697

The respiratory presentation of severe combined immunodeficiency in two Mennonite children at a tertiary centre highlighting the importance of recognizing this pediatric emergency.

Simon Lam, Fotini Dimitriou Kavadas, Seemab Haider, Mary Elizabeth Noseworthy.   

Abstract

Severe combined immunodeficiency (SCID) is considered to be a pediatric emergency, with respiratory distress being the most common presenting symptom. The authors present two cases of SCID in children <4 months of age with respiratory distress at a tertiary care centre due to a recently described homozygous CD3 delta mutation found only in the Mexican Mennonite population. Failure to respond to broad-spectrum antibiotics prompted investigation for possible SCID. Bronchial alveolar lavage fluid from both patients grew Pneumocystis jiroveci, and flow cytometry revealed absent T cells. The CD3 delta gene is believed to be important in T cell differentiation and maturation. The present article reminds pediatricians and pediatric respirologists that the key to diagnosing SCID is to have a high index of suspicion if there is poor response to conventional therapies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24288697      PMCID: PMC3938231          DOI: 10.1155/2014/404506

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  8 in total

1.  Screening newborns for primary T-cell immunodeficiencies: consensus and controversy.

Authors:  Deborah J Accetta Pedersen; James Verbsky; John M Routes
Journal:  Expert Rev Clin Immunol       Date:  2011-11       Impact factor: 4.473

Review 2.  The long quest for neonatal screening for severe combined immunodeficiency.

Authors:  Rebecca H Buckley
Journal:  J Allergy Clin Immunol       Date:  2012-01-24       Impact factor: 10.793

3.  Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival.

Authors:  Laurie A Myers; Dhavalkumar D Patel; Jennifer M Puck; Rebecca H Buckley
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

Review 4.  Systematic evidence review of newborn screening and treatment of severe combined immunodeficiency.

Authors:  Ellen A Lipstein; Sienna Vorono; Marsha F Browning; Nancy S Green; Alex R Kemper; Alixandra A Knapp; Lisa A Prosser; James M Perrin
Journal:  Pediatrics       Date:  2010-04-19       Impact factor: 7.124

Review 5.  CD3 deficiencies.

Authors:  Alain Fischer; Geneviève de Saint Basile; Françoise Le Deist
Journal:  Curr Opin Allergy Clin Immunol       Date:  2005-12

6.  Early diagnosis of severe combined immunodeficiency syndrome.

Authors:  R A Hague; S Rassam; G Morgan; A J Cant
Journal:  Arch Dis Child       Date:  1994-04       Impact factor: 3.791

7.  Effect of CD3delta deficiency on maturation of alpha/beta and gamma/delta T-cell lineages in severe combined immunodeficiency.

Authors:  Harjit K Dadi; Amos J Simon; Chaim M Roifman
Journal:  N Engl J Med       Date:  2003-11-06       Impact factor: 91.245

8.  European experience of bone-marrow transplantation for severe combined immunodeficiency.

Authors:  A Fischer; P Landais; W Friedrich; G Morgan; B Gerritsen; A Fasth; F Porta; C Griscelli; S F Goldman; R Levinsky
Journal:  Lancet       Date:  1990-10-06       Impact factor: 79.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.